En Carta Diagnostics raises $5.3M (France, Jul 2026)
Reach the investors backing rounds like this
Backed by Blue Forest Ventures, Ring Capital +3 more · verified emails and LinkedIn on Datapile
En Carta Diagnostics secures 5 million euros for home testi - n24.com.tr
En Carta Diagnostics is a Paris-based deeptech startup focused on developing home-based molecular diagnostic tools for Lyme disease and sexually transmitted infections. The company aims to provide results within 30 minutes, matching the precision of laboratory PCR tests, and has recently achieved FDA Breakthrough Device Designation.
En Carta Diagnostics secures 5 million euros for home testi n24.com.tr
| Sep 04, 2026 | Davis | $5.5M | Pre-seed | France |
| Aug 25, 2026 | ArcSpace | $2.1M | — | France |
| Aug 04, 2026 | Shiplog | $858K | — | France |
| Jul 27, 2026 | ENGO Eyewear | $5.5M | — | France |
11,392 investors back startups in France
You just read who funded En Carta Diagnostics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.